CoChat

Secretin/secretin receptor signaling mediates biliary damage and liver fibrosis in early‐stage primary biliary cholangitis

Open access
Kennedy, Lindsey, Francis, Heather, Invernizzi, Pietro, Venter, Julie, Wu, Nan, Carbone, Marco, Eric Gershwin, M., Bernuzzi, Francesca, Franchitto, Antonio, Alvaro, Domenico, Marzioni, Marco, Onori, Paolo, Gaudio, Eugenio, Sybenga, Amelia, Fabris, Luca, Meng, Fanyin, Glaser, Shannon, Alpini, Gianfranco · 2019 · The FASEB Journal
Cited by 47

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Primary biliary cholangitis (PBC) primarily targets cholangiocytes and is characterized by liver fibrosis and biliary proliferation. Activation of the secretin (Sct)/secretin receptor (SR) axis, expressed only by cholangiocytes, increases biliary proliferation, liver fibrosis, and bicarbonate secretion. We evaluated the effectiveness of SR antagonist treatment for early‐stage PBC. Male and female dominant‐negative TGF‐β receptor II (dnTGF‐βRII) (model of PBC) and wild‐type mice at 12 wk of age were treated with saline or the SR antagonist, Sec 5‐27, for 1 wk. dnTGF‐βRII mice expressed features of early‐stage PBC along with enhanced Sct/SR axis activation and Sct secretion. dnTGF‐βRII mice had increased biliary proliferation or senescence, inflammation, and liver fibrosis. In dnTGF‐βRII mice, there was increased microRNA‐125b/TGF‐β1/TGF‐β receptor 1/VEGF‐A signaling. Human early‐stage PBC patients had an increase in hepatobiliary Sct and SR expression and serum Sct levels. Increased biliary Sct/SR signaling promotes biliary and hepatic damage during early‐stage PBC.—Kennedy, L., Francis, H., Invernizzi, P., Venter, J., Wu, N., Carbone, M., Gershwin, M. E., Bernuzzi, F., Franchitto, A., Alvaro, D., Marzioni, M., Onori, P., Gaudio, E., Sybenga, A., Fabris, L., Meng, F., Glaser, S., Alpini, G. Secretin/secretin receptor signaling mediates biliary damage and liver fibrosis in early‐stage primary biliary cholangitis. FASEB J. 33, 10269–10279 (2019). www.fasebj.org

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fj.201802606r

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 47

Metadata

Authors
Kennedy, L., Francis, H., Invernizzi, P., Venter, J., Wu, N., Carbone, M., Eric Gershwin, M., Bernuzzi, F., Franchitto, A., Alvaro, D., Marzioni, M., Onori, P., Gaudio, E., Sybenga, A., Fabris, L., Meng, F., Glaser, S., & Alpini, G.
Venue
The FASEB Journal
Publisher
Wiley
Published
2019-06-28
Volume
33
Issue
9
Pages
10269-10279
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W2954206839
Cited by
47
References
11
FWCI
3.25
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Secretin/secretin receptor signaling mediates biliary damage and liver fibrosis in early‐stage primary biliary cholangitis. https://app.cochat.ai/papers/10.1096/fj.201802606r
The paper
Kennedy, L., Francis, H., Invernizzi, P., Venter, J., Wu, N., Carbone, M., Eric Gershwin, M., Bernuzzi, F., Franchitto, A., Alvaro, D., Marzioni, M., Onori, P., Gaudio, E., Sybenga, A., Fabris, L., Meng, F., Glaser, S., & Alpini, G. (2019). Secretin/secretin receptor signaling mediates biliary damage and liver fibrosis in early‐stage primary biliary cholangitis. The FASEB Journal. https://doi.org/10.1096/fj.201802606r

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.